GLP-1 Use Reduces Risk of MGUS Progression in Some Veterans

Glucagon-like peptide 1 (GLP-1) receptor agonists have gained huge popularity as they have demonstrated the ability to substantially reduce both blood-glucose levels and weight. In addition, recent research suggests cardiovascular and renal benefits to their use in certain populations.

We survived!

As 2023 passes into history, I cannot suppress the feeling that I am on a perpetual rollercoaster ride, from which I cannot get off. The planet continues to warm, sea levels keep rising, frequent weather extremes, war in Ukraine and Israel, inflation, COVID, and so on. In the era of instant and constant media, one can be challenged to find a respite from the pressure of modern life. For many federal healthcare professionals, the barrage of world events is compounded by the everyday drama of patient care. Society recognizes the extraordinary daily challenges healthcare providers face, which explains our exulted status within the social fabric.

Strict LDL-C Lowering Linked to Diabetes Progression

While some guidelines recommend statin use to achieve low-density lipoprotein cholesterol (LDL-C) goal under 70 mg/dL for primary prevention of atherosclerotic cardiovascular disease (ASCVD) in patients at higher risk, others recommend against a target LDL-C level.